Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

708 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA.
Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjöholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR. Seelen MA, et al. Among authors: daha mr. J Immunol Methods. 2005 Jan;296(1-2):187-98. doi: 10.1016/j.jim.2004.11.016. Epub 2004 Dec 15. J Immunol Methods. 2005. PMID: 15680163
In situ deposition of complement in human acute brain ischaemia.
Pedersen ED, Løberg EM, Vege E, Daha MR, Maehlen J, Mollnes TE. Pedersen ED, et al. Among authors: daha mr. Scand J Immunol. 2009 Jun;69(6):555-62. doi: 10.1111/j.1365-3083.2009.02253.x. Scand J Immunol. 2009. PMID: 19439017 Free article.
Mannose-binding lectin engagement with late apoptotic and necrotic cells.
Nauta AJ, Raaschou-Jensen N, Roos A, Daha MR, Madsen HO, Borrias-Essers MC, Ryder LP, Koch C, Garred P. Nauta AJ, et al. Among authors: daha mr. Eur J Immunol. 2003 Oct;33(10):2853-63. doi: 10.1002/eji.200323888. Eur J Immunol. 2003. PMID: 14515269 Free article.
Autoantibodies against C1q: view on clinical relevance and pathogenic role.
Siegert CE, Kazatchkine MD, Sjöholm A, Würzner R, Loos M, Daha MR. Siegert CE, et al. Among authors: daha mr. Clin Exp Immunol. 1999 Apr;116(1):4-8. doi: 10.1046/j.1365-2249.1999.00867.x. Clin Exp Immunol. 1999. PMID: 10209498 Free PMC article. Review. No abstract available.
'Stealth' corporate innovation: an emerging threat for therapeutic drug development.
Mastellos DC, Blom AM, Connolly ES, Daha MR, Geisbrecht BV, Ghebrehiwet B, Gros P, Hajishengallis G, Holers VM, Huber-Lang M, Kinoshita T, Mollnes TE, Montgomery RA, Morgan BP, Nilsson B, Pio R, Ricklin D, Risitano AM, Taylor RP, Mantovani A, Ioannidis JPA, Lambris JD. Mastellos DC, et al. Among authors: daha mr. Nat Immunol. 2019 Nov;20(11):1409-1413. doi: 10.1038/s41590-019-0503-1. Nat Immunol. 2019. PMID: 31562490 Free PMC article.
Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development.
Mastellos DC, Blom AM, Connolly ES, Daha MR, Geisbrecht BV, Ghebrehiwet B, Gros P, Hajishengallis G, Holers VM, Huber-Lang M, Kinoshita T, Mollnes TE, Montgomery RA, Morgan BP, Nilsson B, Pio R, Ricklin D, Risitano AM, Taylor RP, Mantovani A, Ioannidis JPA, Lambris JD. Mastellos DC, et al. Among authors: daha mr. Nat Immunol. 2019 Nov;20(11):1556. doi: 10.1038/s41590-019-0531-x. Nat Immunol. 2019. PMID: 31605100
708 results